Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Acta Gastroenterologica Latinoamericana
|
October 1, 1973
[Editorial: Biliary lithiasis (author's transl)]
P A Mazure, R Groszmann
Gastroenterology
|
July 1, 1972
Circulation times in the splanchnic and hepatic beds in alcoholic liver disease
B Kotelanski, R Groszmann, J N Cohn
The American Journal of Medicine
|
December 1, 1972
Quantitation of portasystemic shunting from the splenic and mesenteric beds in alcoholic liver disease
R Groszmann, B Kotelanski, J N Cohn, et al.
European Heart Journal
|
January 1, 1988
Organic nitrates in portal hypertension
A T Blei, D Ganger, H L Fung, et al.
The Journal of Surgical Research
|
April 1, 1990
Decreased mesenteric vascular response to angiotensin II in portal hypertension
J V Sitzmann, S S Li, Y P Wu, et al.
Hepatology (Baltimore, Md.)
|
January 1, 1989
Long-term hemodynamic effects of ketanserin, a 5-hydroxytryptamine blocker, in portal hypertensive patients
J Vorobioff, G Garcia-Tsao, R Groszmann, et al.
Gut
|
February 13, 2002
Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?
A K Burroughs, R Groszmann, J Bosch, et al.
Journal of Hepatology
|
May 1, 1992
Definitions, methodology and therapeutic strategies in portal hypertension. A Consensus Development Workshop, Baveno, Lake Maggiore, Italy, April 5 and 6, 1990
R de Franchis, J P Pascal, E Ancona, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Acta Gastroenterologica Latinoamericana
|
October 1, 1973
[Editorial: Biliary lithiasis (author's transl)]
P A Mazure, R Groszmann
Gastroenterology
|
July 1, 1972
Circulation times in the splanchnic and hepatic beds in alcoholic liver disease
B Kotelanski, R Groszmann, J N Cohn
The American Journal of Medicine
|
December 1, 1972
Quantitation of portasystemic shunting from the splenic and mesenteric beds in alcoholic liver disease
R Groszmann, B Kotelanski, J N Cohn, et al.
European Heart Journal
|
January 1, 1988
Organic nitrates in portal hypertension
A T Blei, D Ganger, H L Fung, et al.
The Journal of Surgical Research
|
April 1, 1990
Decreased mesenteric vascular response to angiotensin II in portal hypertension
J V Sitzmann, S S Li, Y P Wu, et al.
Hepatology (Baltimore, Md.)
|
January 1, 1989
Long-term hemodynamic effects of ketanserin, a 5-hydroxytryptamine blocker, in portal hypertensive patients
J Vorobioff, G Garcia-Tsao, R Groszmann, et al.
Gut
|
February 13, 2002
Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?
A K Burroughs, R Groszmann, J Bosch, et al.
Journal of Hepatology
|
May 1, 1992
Definitions, methodology and therapeutic strategies in portal hypertension. A Consensus Development Workshop, Baveno, Lake Maggiore, Italy, April 5 and 6, 1990
R de Franchis, J P Pascal, E Ancona, et al.
Page
of 1